πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 9 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12257224

Methods of administration for highly water-soluble salts of a short acting phenylalkylamin

Milestone Pharmaceuticals Inc. Β· Granted Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10117848

Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and

Milestone Pharmaceuticals Inc. Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10010522

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10010523

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10010524

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9737503

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9463179

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9227918

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501727

Short acting benzothiazepine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted